Why Pharma Risk Registers Misclassify Their Biggest Third-Party Exposures

InnovationWhy Pharma Risk Registers Misclassify Their Biggest Third-Party ExposuresByMaman Ibrahim,Forbes Councils Member.for Forbes Technology CouncilCOUNCIL POSTExpertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. | Membership (fee-based)Jun 04, 2026, 09:15am EDTMaman Ibrahim is a cyber and digital risk executive, helping boards, CRO, CIO, and CISO turn risk work into decisions, delivery, and proof. gettyIn my work advising pharmaceutical leadership teams on risk governance, I see the same pattern recur with surprising regularity: a third-party clinical platform suffers a control failure. Trial data is exposed through a poorly secured interface, or a contracted research partner mishandles regulated records.Within hours, five functions are discussing the incident, each describing it in the language of its own discipline. Cyber treats it as an intrusion. The regulatory team frames it as a trial data integrity issue requiring notification to authorities. Legal records it as exposure of sensitive scientific material. Finance models the impact on pipeline value. Vendor risk recognizes it as a third-party governance failure, but its perspective is folded quietly into the broader discussion.​In many cases, the vendor risk perspective is the one most directly aligned with where the underlying failure occurred.​ However, in most risk registers I have reviewed, teams log the same event under cyber, regulatory or operational risk, while reducing the vendor dimension to a footnote. The result is a register that captures the consequences of a failure but loses the cause.​Why The Root Cause Gets Lost In The Response​​It is natural for a function to claim ownership of a risk when it is absorbing the impact. When regulators question trial data integrity, regulatory manages the authority response. When attackers exploit a weak interface, cyber leads the remediation. When commercial value shifts, finance carries the model. Pain...